Hepatocellular carcinoma (HCC) is a common form of tumor worldwide. The evidence suggests that the incidence of HCC is rising, and it has become a major health problem. Its multistage process involves multiple factors in its etiology and many gene-environment interactions, including infection with hepatitis B or C (HBV or HCV), and ingestion of aflatoxin-contaminated food, and alcohol[@b1]. The development of HCC is associated with multiple changes at the messenger RNA (mRNA) and/or protein levels, some of which serve as tumor markers, e.g., glypican-3 (GPC3)[@b2] (gi\|23271174), α-fetoprotein[@b3] (gi\|178236), and less specifically, cyclin D1[@b4] (gi\|23273807) and the proliferating cell nuclear antigen[@b5].

Medicinal mushrooms are among a number of well-known agents in Asian countries that have been taken orally since ancient times to combat viral and bacterial infections. It has been well-established that many commonly used compounds extracted from mushrooms act as immune modulators or as biological response modifiers (BRMs)[@b6][@b7][@b8]. We recently isolated the polysaccharides from *Phellinus linteus* (PL), *Ganoderma lucidum* (GL), and *Auriculari auricula* (AA) and investigated the molecular mechanisms underlying the anti-tumor properties of these polysaccharides in human liver cancer cells. We demonstrated that polysaccharides have antiproliferative effects in HepG2 and Bel-7404 human hepatoma cells. The growth inhibition of HepG2 and Bel-7404 cells by PL, GL, and AA is mediated through the induction of apoptosis and through G~1~- or S-phase cell cycle arrest. The mechanisms for the arrest involve the suppression of AKT (gi\|63102175) activity via the inhibition of AKT phosphorylation at Thr^308^ and/or Ser^473^, the activation of Bcl-2 (gi\|179371) family proteins, an increase in mitochondrial cytochrome C (gi\|11128019) and Smac (gi\|9454219) release, an enhancement in the expression of p27^Kip^ (gi\|2982673) or p21^Cip^ (gi\|453135), and the suppression of the activities of cyclin D1/CDK4 (gi\|4502735) and cyclin E (gi\|6630609)/CDK2 (gi\|312803)[@b9]. However, the effects of mushroom polysaccharides on the identification of tumor markers in HepG2 cells have not been investigated. Proteomic studies of clinical tumor samples have led to the identification of cancer-specific protein markers, and these provide a basis for the development of new methods for the early diagnosis and early detection of cancers and may provide clues to improve our understanding of the molecular mechanism of cancer progression. Bioinformatics is an important technology that supports proteomics not only by providing an efficient means of analysis of the protein data but also by comprehensively evaluating functions of the known or new proteins. The technology includes Gene Ontology (GO) analysis, pathway enrichment and Protein-Protein Interaction (PPI) analysis. To identify the proteins and markers from HepG2 cells that were induced by PL, GL, and AA, a proteomic and bioinformatic approach was used. A number of proteins were separated by two-dimensional electrophoresis (2DE) and identified using mass spectrometry. All of the differentially expressed proteins were analyzed using bioinformatic technology. This analysis included the systematic cataloging of the protein expression levels at a large scale. Such studies may help to provide significant molecular targets in cancer progression and may have tremendous meaning for the utilization of valuable medicinal mushroom resources and the development of natural anti-tumor foods.

Results
=======

Overview of the analysis of the protein expression profiles of the samples
--------------------------------------------------------------------------

Our previous experiments had proved that PL, GL, and AA had obvious inhibitory effects on HepG2 cells and induced their apoptosis[@b9]. We therefore subjected PL-, GL-, and AA-treated HepG2 cells to proteomics analyses. To ensure the quality and reproducibility of the results, the 2DE was performed at least three times under the same conditions.

2DE gel separation of the proteins from 12 pairs of HepG2 cells treated or not treated with PL, GL, and AA was performed. A series of 2DE maps for the soluble fraction proteins was constructed. Representative 2DE gel images following the silver staining of control HepG2 cells ([Fig. 1a](#f1){ref-type="fig"}) or those treated with PL, GL, and AA ([Fig. 1b--d](#f1){ref-type="fig"}) were produced using UMAX PowerLook 2100XL (Willich, Germany). The comparison of the differential protein expression between the control and treated cells shown in the 2DE images was performed using Image Master 2D Platinum software (Version 5.0, GE Healthcare). Under the same conditions, each gel contained approximately 656 ± 23 protein spots on average, and a total of 104 differentially expressed protein spots was detected.

The resulting identified spots were mapped onto the analytical gels, which were stained with Coomassie brilliant blue (CBB R-250). Based on these analyses, 104 differentially expressed protein spots were excised and subjected to in-gel digestion followed by peptide mass fingerprinting for protein identification. The criteria used to accept the identifications included the extent of sequence coverage, the number of peptides matched, the probability score, and whether the human protein appeared as one of the top candidates in the first-pass search, in which no restrictions were applied to the species of origin.

The NCBInr human database (Human, 244004 sequences) was searched using the MASCOT software, and 59 differentially expressed proteins were evaluated by MALDI-TOF-MS mass spectrometry analysis. The results of the identification are summarized in [Table 1](#t1){ref-type="table"}. For each identified protein, a probability-based score greater than 75 was considered significant (P \< 0.05). The identifications of spots No. 12 ([Fig. 2a](#f2){ref-type="fig"}) and No. 96 ([Fig. 2b](#f2){ref-type="fig"}) are shown as an example.

GO, Pathway enrichment and PPI analysis
---------------------------------------

The 59 differentially expressed proteins identified by the MASCOT analysis were subjected to Gene Ontology analysis (GO). This analysis identified 400 biological processes (BP), 133 cell components (CC) and 146 molecular functions (MF) that were enriched for this dataset([Supplementary Table S1](#S1){ref-type="supplementary-material"}). Of these 259 BP, 66 CC and 88 MF had P-values \< 0.05. As seen in [Fig. 3](#f3){ref-type="fig"}, the BP analysis showed that 2.28% of the identified proteins were involved in the gene expression process, while 1.98% of the proteins were associated with small molecule metabolic processes. Another 1.67% of the proteins were involved in the negative regulation of apoptotic processes. The CC analysis revealed that most of the identified proteins were distributed in the extracellular vesicular exosomes, cytosol, cytoplasm and membranes. The MF analysis demonstrated that 13.73% of the identified proteins had protein binding activity, and 6.34% of them had poly(A) RNA binding activity. The remaining proteins had various binding activities, including ribosome binding activity, cytokine binding activity, transcription factor binding activity and others. The up-regulated protein 14-3-3 (gi\|5803227) and the down-regulated protein DJ-1 (gi\|31543380) were mainly distributed in the extracellular vesicular exosomes, combining function and involved in apoptotic process.

In further analyses of the biological pathways, 78 KEGG pathways were enriched for this dataset ([Supplementary Table S2](#S1){ref-type="supplementary-material"}). The top 10 pathways (P \< 0.05) included antigen processing and presentation, proteasome, Epstein-Barr virus infection, protein processing in endoplasmic reticulum, glycolysis/gluconeogenesis, RNA degradation, amoebiasis, spliceosome, Legionellosis and pathogenic *Escherichia coli* infection ([Table 2](#t2){ref-type="table"}). A number of metabolic pathways were changed in HepG2 cells treated with polysaccharides. Three of the most enriched pathways were Epstein-Barr virus infection, protein processing in endoplasmic reticulum and antigen processing and presentation. There were 7, 6, and 5 proteins involved in these pathways, respectively.

The PPI analysis evaluated the interaction networks affected by the polysaccharides in HepG2 cells. These networks involved 59 proteins and 10 KEGG pathways ([Fig. 4](#f4){ref-type="fig"}). The interactions of the proteins in these networks can be either direct or indirect. The nodes represent the proteins, and the lines between the nodes indicated direct or indirect protein-protein interaction modes. In the results of the PPI analysis, several proteins that directly interact with 14-3-3 were identified: t-complex polypeptide 1 (gi\|36796), ATP synthase subunit beta (gi\|179279) and phosphatase 2A regulatory subunit (gi\|189428), whereas the protein DJ-1, the 60S acidic ribosomal protein P0 (gi\|16933546), the prosome beta-subunit and others were identified as indirectly interacting proteins. Thus, up-regulation 14-3-3 may indirectly affect the down-regulation of protein DJ-1 in HepG2 cells treated with polysaccharide.

Identification by Real-time quantitative PCR and Western blotting
-----------------------------------------------------------------

On the basis of the PPI results, two important proteins (DJ-1 and 14-3-3) were selected from 59 differentially expressed proteins for further study. Absolute quantification of the DJ-1 and 14-3-3 target genes was accomplished using Real-time quantitative PCR. The standard curve for DJ-1 showed an R^2^ = 0.999 and an amplification efficiency of 100.2%, and the standard curve for 14-3-3 displayed an R^2^ = 0.998 and an amplification efficiency of 104.9%. The two solubility curves, both of which comprised single peaks, showed no nonspecific amplification. The expression of the DJ-1 and 14-3-3 mRNA levels is shown in [Fig. 5](#f5){ref-type="fig"}. Overall, the evaluation of the DJ-1 and 14-3-3 mRNA expressed in HepG2 cells showed that the mRNA expression of DJ-1 was down-regulated and that of 14-3-3 was up-regulated in the mushroom polysaccharide-treated HepG2 cells. Compared with the control HepG2 cells, a highly significant decrease in the DJ-1 expression level was observed at 0.25--2.0 mg/mL of the GL- and AA-treated groups, but in PL-treated group, highly significant decreases in the expression levels were observed at 0.5--2.0 mg/mL, but there was no significant difference at 0.25 mg/mL. However, the expression levels of 14-3-3 mRNA were generally elevated. The significance of the difference among the three groups varied. Compared with the control HepG2 cells, in the AA-treated group, the increases in the 14-3-3 expression level were highly significant at 0.5--2.0 mg/mL, whereas the increases in the expression levels were highly significant at 0.25 mg/mL and 1-2 mg/mL in the GL-treated group. In the PL-treated group, highly significant increases in the expression levels were observed at 1--2 mg/mL and a significant difference was found at 0.5 mg/mL, but the difference at 0.25 mg/mL was not significant. The changes in the mRNA levels were for both proteins were consistent with the proteomics results.

To evaluate the protein expression, HepG2 cells were treated with PL, GL, or AA, and β-actin was used as a control for the Western blotting analyses. The expression levels of DJ-1 in all of the groups were down-regulated, and the magnitude of the reduction increased with increasing concentration ([Fig. 6a](#f6){ref-type="fig"}). However, 14-3-3 was up-regulated with increasing concentrations of the polysaccharides. HepG2 cells treated with GL and AA showed a trend toward increases, whereas HepG2 cells treated with PL showed little change in this protein ([Fig. 6b](#f6){ref-type="fig"}). The statistical analysis showed that the results were consistent with the proteomics and qRT-PCR results.

Discussion and Conclusion
-------------------------

PL, GL, and AA are basidiomycete fungi located mainly in Asia and tropical America. These fungi have gained significant recognition as medicinal mushrooms in traditional Oriental medicine. A large number of studies have shown that these fungal polysaccharides are associated with effects on immune function regulation[@b10], anti-mutagenic activity[@b11], and liver fibrosis inhibition[@b12]. Currently, many fungal polysaccharides are present in functional foods and drugs that are used for adjuvant cancer therapy, including lentinan[@b13], *Coriolus versicolor* polysaccharides[@b14], and *Polyporus* polysaccharides[@b15]. Fungal polysaccharides, particularly PL, are widely found in China, and their pharmacological effects have been widely proven[@b16][@b17]. Due to their broad potential applications in functional health foodstuffs, studies of fungal polysaccharides are of considerable value in the development of these foods.

This study was based on an ongoing proteomic and bioinformatic analysis of HepG2 cells treated with polysaccharides with the aim of screening protein markers for the diagnosis of HCC. The combination of two-dimensional electrophoresis and mass spectrometry is the most effective way to study complex patterns of protein expression[@b18]. Subsequent bioinformatic analyses can identify the target proteins or genes[@b19]. The measurement of the protein expression patterns of normal and diseased tissues or cell populations will lead to the characterization of diagnostic and prognostic markers. These data can be further employed for the analysis of the disease stages and which may also have an impact on the development of future therapies[@b20]. Thus, small clusters of proteins are preferred as representing ideal diagnostic markers that would enable an easier and more accurate diagnosis of the diseases and the potential for improved therapy[@b21][@b22].

In the preparation of the 2DE maps presented in this study, tissue samples from separate individuals were used without pooling the samples. The total homogenates were fractionated by ultracentrifugation into their soluble fractions[@b23]. To minimize the influence of the methodology, we attempted, whenever possible, to ensure the similarity of the 2DE-PAGE protocols. Our initial analyses of twelve samples indicated that the overall protein pattern remained very similar across the samples. The 2DE pattern of the control and treated cells revealed a number of polypeptides that are associated with HCC, i.e., these polypeptides were expressed in HepG2 cells treated with polysaccharides but were absent in the normal HepG2 cells.

We identified 59 protein spots that were expressed in HepG2 cells treated with the polysaccharides but were absent in the normal HepG2 cells. Of the 59 identified proteins, spots 12 and 96 were present as multiple spots on the 2DE gels. The GO and KEGG pathway analyses are the most reliable methods to provide a better understanding of the BP, CC and MF of the target proteins[@b24]. The differentially expressed proteins were classified into different functional categories according to the GO analysis. These categories included gene expression, mRNA metabolic process, extracellular vesicular exosomes, cytosol, cytoplasm, protein binding, poly(A) RNA binding and others. The KEGG pathway analysis showed that antigen processing and presentation pathway (hsa04612), proteasome pathway (hsa03050) and Epstein-Barr virus infection (hsa05169) were the top three pathways with P \< 0.05. We found that 14-3-3 was involved in many KEGG pathways, some of which were closely related with tumor markers and cellular signal transduction, including Epstein-Barr virus infection pathway, Hippo signaling pathway, viral carcinogenesis pathway, cell cycle pathway and PI3K-AKT signaling pathway. This result implies that resistance mechanisms associated with metabolism are important in HepG2 treated with polysaccharides.

In this study, we identified the protein interaction networks included in cellular functions and metabolisms, which are associated with cellular signal transduction closely, some important proteins, including ATP synthase subunit beta, vimentin and heat shock 70 kDa protein 1 A/1B also appeared in the biological networks. These proteins could interact with each other and together affect the expression of proteins in the polysaccharide-treated HepG2 cells. Additionally, these proteins were also closely related to the tumor biomarkers[@b25][@b26][@b27] for HCC. Therefore, the PPI results revealed that several signal pathways were affected by the polysaccharides, and some of these may be identified and serve as diagnostic and prognostic markers in HCC[@b28][@b29].

DJ-1 was first identified as a novel candidate oncogene product that transforms mouse NIH3T3 cells in cooperation with activated ras[@b30]. The genomic DNA of both human and mouse DJ-1 comprises seven exons, and exons 2--7 encode the DJ-1 proteins. The human DJ-1 gene maps to chromosome 1p36.2-p36.3, which represents a hot spot of chromosome abnormalities that have been found in several tumors[@b31]. DJ-1 is preferentially expressed in the testes and moderately expressed in other tissues, and it is translocated from the cytoplasm to the nucleus during the cell cycle after mitogen stimulation. These observations suggest that DJ-1 has a growth-related function. Liu et al. found that the DJ-1 protein is clearly up-regulated in HCC tissues[@b32]. However, in the present study, the DJ-1 protein was down-regulated in the PL-treated HepG2 cells. A recent study found that DJ-1 was down-regulated in the *Radix Rehmanniae Preparata* polysaccharide-treated in hippocampus of rats[@b33]. The DJ-1 protein participates in a number of apoptotic pathways, and the apoptosis is inhibited by preventing the oxidative damage by free radicals[@b34]. DJ-1 can prevent TRAIL-induced apoptosis by inhibiting the formation of the death-inducing signaling complex (DISC)[@b35]. To prevent apoptosis, DJ-1 and the Fas death domain-associated protein (Daxx) (gi\|48146287) combine in the nucleus, thus preventing Daxx from associating with ASK1 (gi\|5174547) and undergoing a translocation from the nucleus to the cytoplasm[@b36]. The DJ-1 protein negatively regulate the activity of PTEN (gi\|4240387)[@b37]. Therefore, a lower expression of DJ-1 can decrease the phosphorylation of PKB/Akt, whereas a higher expression of DJ-1 can increase the PKB/Akt phosphorylation and cell survival[@b38]. Studies have shown that abnormal expression of DJ-1 plays an important role in the invasion and metastasis of HCC[@b39][@b40]. Under low oxygen conditions, the stability of the transcription factor HIF1 (gi\|16611719) mainly depends on the PI3K/Akt/mTOR signaling pathways. The DJ-1-regulated expression of Akt and mTOR (gi\|4826730) is crucial to maintaining the stability of HIF1. DJ-l can also regulate the activity of AMPK (gi\|786491). The carcinogenic activity of DJ-1 regulates mTOR and AMPK functions as activated factor of HIF1 upstream function of cancer cells[@b41]. These findings suggest that the DJ-1 protein will be useful as a prognostic biomarker for HCC.

The 14-3-3 proteins are expressed in all eukaryotic cells, and their amino acid sequences are highly conserved from yeast to mammals. Seven isoforms encoded by seven distinct genes have been identified in mammals, more than 10 isoforms have been identified in plants, and two isoforms have been identified in yeast, Drosophila, and *C. elegans*. Interestingly, the yeast 14-3-3 genes are functionally interchangeable with the plant and mammalian isoforms, which indicates a high level of functional conservation of the gene products. The 14-3-3 proteins assemble as stable homo- and heterodimers[@b42][@b43][@b44][@b45]. All of the 14-3-3 proteins appear to share similar tertiary structures, which were first defined for the τ and ζ isoforms[@b46]. The 14-3-3 proteins are a family of conserved regulatory molecules that are expressed in all eukaryotic cells. A striking feature of the 14-3-3 proteins is their ability to bind a multitude of functionally diverse signaling proteins, including kinases, phosphatases, and transmembrane receptors. This plethora of interacting proteins allows 14-3-3 to play important roles in a wide range of vital regulatory processes, including mitogenic signal transduction, apoptotic cell death, and cell cycle control. Recent studies have suggested that 14-3-3 may inhibit apoptosis and is involved in tumor genesis and development, and its protein or gene is usually abnormally expressed in a variety of human malignancies. Additional studies on the 14-3-3σ (gi\|5454052) protein show that this protein can exhibit an upward or downward trend during the development of tumors. In addition, the 14-3-3σ protein has become a new molecular marker and a new drug target for the treatment of malignant tumors, which forms the basis for important theoretical and practical knowledge. In this review, we examined the interactions between 14-3-3 and other proteins, including ATP synthase subunit beta, DJ-1, keratin and others, and signaling pathways that involve 14-3-3, and discussed the expression of 14-3-3 in polysaccharide-treated HepG2 cells.

In conclusion, the mechanisms for the polysaccharide-treated effects in are complex. Our data showed the changes in the expression of only a few of the differentially expressed proteins and the results of the polysaccharide-treated effects on PPI. Further basic and clinical investigations will be needed to determine whether these proteins can be used as markers for HCC and to develop natural anti-tumor foods.

Methods
=======

Cells and reagents
------------------

The PL, GL, and AA powders were purchased from Zhoushan-Tech (Shanghai, China) and purified using ethanol precipitation methods followed by DEAE-cellulose and gel permeation chromatography[@b47]. The purified component was single fraction. The human HCC cell line HepG2 (American Type Culture Collection ATCC) was cultured in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum (Hyclone, Thermo Scientific, USA), 100 units mL^−1^ penicillin, 100 g mL^−1^ streptomycin at 37 °C in an atmosphere containing 5% CO~2~. Carbamide, sulfocarbamide, DTT, CHAPS, NL IPG buffer (pH 4--7), and IPG gels were purchased from Amresco. Anti-mouse antibodies (Cell Signaling), including anti-DJ-1 and anti-14-3-3 protein primary antibodies and secondary antibody, β-actin, a Real-time quantitative PCR kit (Platinum^®^ SYBR^®^ Green qPCR SuperMix-UDG; Invitrogen), TRIzol reagent (Invitrogen) and TIANScript II RT Kit (TIANGEN, Beijing, China) were used for the verification tests.

2DE and gel analysis
--------------------

HepG2 cells were treated with PL, GL, or AA (1 mg ml^−1^) for 72 h, and the whole-cell extracts were lysed in RIPA buffer (Thermo Scientific, USA). The samples were prepared for 2DE[@b48]. The first-dimension isoelectric focusing was conducted using a Multiphor II system as described by the manufacturer (Amersham Bioscience Inc.). A precast immobilized pH gradient (IPG) strip (24 cm, pH 4--7, linear gradient) was used for the first-dimensional separation. Samples containing between 700 mg to 1,000 mg total protein were loaded onto an IPG strip, allowed to swell for 16 h and then rehydrated for 24 h. The isoelectric focusing was conducted at 250 V for 3 h, at 500 V for 2 h, followed by 1 h at 1,000 V, a gradient to 10,000 V for 3 h, and then from 10,000 V up to 130,000 V for the pH 4-7 strips. All of the IEF steps were conducted at 20 °C. After the first-dimensional IEF, the IPG gel strips were placed in an equilibration solution (6 mol L^−1^ urea, 200 g L^−1^ SDS, 300 g L^−1^ glycerol, and 50 mol L^−1^ Tris-HCl, pH 8.8) containing 10 g L^−1^ dithiothreitol and shaken for 15 min. The gels were then transferred to an equilibration solution containing 25 g L^−1^ iodoacetamide to alkylate the thiols, shaken for 15 min, and then placed on a 125 g L^−1^ polyacrylamide gel slab. The separation in the second dimension was conducted using a Tris-glycine buffer containing 1 g L^−1^ SDS at a current setting of 5 mA gel^−1^ for the initial 0.5 h and at 18 mA gel^−1^ thereafter; the temperature was maintained at 20 °C.The experiments were carried out in triplicate.

The SDS-PAGE gels were visualized by the modified CBB R-250 staining method. The analytical gels were scanned at a resolution of 300 dpi (dots per inch), and the image analysis was performed with ImageMaster 2D Platinum Software (Version 5.0, GE Healthcare) following the user's manual. The apparent molecular weight of each protein in the gel was determined using protein markers.

In-gel protein digestion
------------------------

The proteins were digested in-gel with bovine trypsin (modified sequencing grade, Roche Molecular Biochemicals) as previously described[@b49]. The gel spots of interest were manually excised, washed twice with 200 μL of distilled water at room temperature for 30 min, washed twice with 200 μL of destaining solution (50% acetonitrile (ACN) and 50 mM ammonium acetate, pH 7.0) at room temperature for 30 min, washed twice with 100 μL of 100% acetonitrile for 5 min, and air-dried. The gel pieces were then rehydrated with 10 μL of trypsin digestion solution (10 ng μL^−1^ trypsin in 25 mM ammonium bicarbonate, pH 8.5) at 4 °C for 1 h and covered with 8 μL of digestion buffer (1 mM calcium chloride and 25 mM ammonium bicarbonate, pH 8.5) at 37 °C for 16 h. After the digestion, the protein peptides were collected, and the minced gels were extracted three times with extraction bufferI (0.1% trifluoroacetic acid, TFA), extraction bufferII (30%ACN, 0.1% TFA) and extraction bufferIII (60% ACN, 0.1% TFA). After each extraction, the samples were centrifuged at 1,000 *x*g for 20 s, and all of the supernatants were combined, vacuum dried, and stored at −80 °C until analysis by mass spectrometry (MS).

The samples weremixed with the matrix solution of α-cyano-4-hydroxycinnamic acid (Bruker-Daltonics, Billerica, MA, USA) in 50% acetonitrile and 0.1% TFA for 30 min. Then, 1.5 μL of the reconstituted in-gel digest sample followed by 1 μL of the matrix solution were spotted on the Anchor chip target plate (600/384 F, Bruker-Daltonics). The dried sample on the target plate was washed twice with 1 μL of 0.1% TFA, incubated for 30 s, and dried for MALDI-TOF-MS analysis.

MALDI-TOF-MS analysis
---------------------

For protein identification, the dried spots were analyzed using a REFLEX-III (Bruker) MALDI-TOF-MS[@b50]. The spectrometer was run in the positive ion mode and in the reflector mode with the following settings: pulsed N2 laser 337 nm, ion source 1 = 19.00 kV, ion source 2 = 16.50 kV, reflector voltage = 20.00 kV, lens voltage = 8.80 kV, pulsed ion extraction time = 80 ns, matrix suppression = 400 Da, and positive reflector mode. At least three different areas of each protein sample on the MALDI target were selected for analysis, and each area was analyzed five times; the averages were used as the standard peak parameters. The MS images were analyzed using X-TOF/X-MASS software (Version 3.2, Bruker-Daltonics, Billerica, MA, USA). The measured tryptic peptide masses were transferred through the MS BioTools program (Bruker-Daltonics) as inputs to search against the taxonomy of Homo in the nonredundant NCBI database (<http://www.ncbi.nlm.nih.gov/>) using MASCOT software (Version 2.2, Matrix Science, London, UK). Good matches were classified as those having a Mascot score higher than 75 (threshold).

Protein data bioinformatic analysis
-----------------------------------

The differentially expressed proteins were subjected to GO analysis, pathway enrichment and PPI analysis. The GO analysis was performed against the DAVID database (<http://david.abcc.ncifcrf.gov/>) and included biological process enrichment (BP), cell component enrichment (CC) and molecular function enrichment (MF). The pathway enrichment used the KEGG database (<http://www.kegg.jp/>) and analyzed the significance of pathway. Base on the interactions among the pathways in the KEGG database, the PPI was built using the STRING database (<http://string.embl.de/>).

Real-time quantitative PCR assay
--------------------------------

The total RNA was extracted using TRIzol reagent and reverse transcribed into the first-strand cDNA using a TIANScript II RT Kit. A control containing no reverse transcriptase was included to confirm the absence of contaminating DNA. The successfully reverse transcribed cDNA was diluted ten-fold and used as the template for the Real-time quantitative PCR (qRT-PCR). The primer sequences are shown below:

DJ-1 (forward), 5′-CGCGGATCCCATGGCTTCCAAAAGAGCT-3′;

DJ-1 (reverse), 5′-CCCGAATTCCTAGTCTTTAAGAACAAG-3′;

14-3-3 (forward), 5′-AAATGTTGTAGGAGCCCGTAGG-3′;

14-3-3 (reverse), 5′-GAAGCATTGGGGATCAAGAACT-3′.

The qRT-PCR was performed using the following temperature conditions: 30 s at 95 °C and 35 cycles of 5 s at 95 °C, 15 s at 58 °C and 20 s at 68 °C, and one final cycle of 15 s at 95 °C, 1 min at 60 °C and 15 s at 95 °C. β-actin was used as the internal control gene, and SYBR Green I was used as fluorochrome. Finally, the coefficient of variation was calculated. The samples had the same mRNA concentration.

Western blot assay
------------------

HepG2 cells were cultured until the cells reached the logarithmic phase of growth and were then treated with PL, GL, or AA. The medium was discarded after the cells had been cultured for 72 h. The cells were washed twice with PBS at 4 °C. The cells in each 25-cm^2^ culture flask were lysed in 0.5 mL of RIPA buffer containing 10 μL of protease inhibitors (Thermo) for 5 min on ice. The lysates were then collected and centrifuged at 2640 *x*g for 5 min. The BCA protein kit was used to determine the total protein content.

The samples were lysed in 5 × buffer and boiled for 5 min, then cooled and applied to a PAGE gel. The voltage for the first gel was 80 V, and the voltage for the second gel was 120 V. The gel electrophoresis was terminated when samples had migrated to approximately 1 cm from the bottom of the PAGE gel. The size of the NC membrane was the same as that of the PAGE gel. To ensure a minimum number of air bubbles, every step was performed submerged in the transfer buffer. The PAGE gel, NC membrane, the filter plate, and a spongy cushion were layered in that order and subjected to electrophoresis at 15 V for 30 min. The NC membrane was washed three times with TBST for 10 min, and 5% skim milk was then added. The membrane was then incubated overnight at 4 °C. The NC membrane was washed three times with TBST for 10 min. The membrane was then incubated with the primary antibody, which was diluted 1:100 in TBS, for 1 h and then washed three times with TBST for 10 min. The membrane was then incubated with the secondary antibody diluted in TBS for 1 h, washed three times with TBST for 10 min, and developed with a WB ultra-sensitive light-emitting liquid using an LAS-3000 imaging system (FUJIFILM, Japan).

Statistical analysis of the data
--------------------------------

The experiments were carried out in triplicate. The data are expressed as the means ± standard error of mean (SEM) and were statistically tested by performing *t*-tests and analysis of variance (ANOVA) using SPSS 19.0 software (Chicago, IL, USA). P \< 0.05 was considered statistically significant.
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![Comparison of a 2DE image of control HepG2 cells with those of the mushroom polysaccharide-treated HepG2 cells.\
(**a**) A 2DE image of control HepG2 cells. (**b**) A 2DE image of HepG2 cells treated with the PL polysaccharides. (**c**) A 2DE image of HepG2 cells treated with the GL polysaccharides. (**d**) A 2DE image of HepG2 cells treated with the AA polysaccharides. The red, blue and green symbols indicate differentially expressed proteins, down-regulated proteins, and up-regulated proteins, respectively.](srep23565-f1){#f1}

![The representative MALDI-TOF-MS maps.\
(**a**) PMF of 14-3-3. (**b**) PMF of DJ-1.](srep23565-f2){#f2}

![Gene Ontology classifications of proteins differentially expressed between normal HepG2 cells and the cells treated with the polysaccharides.\
The differentially expressed proteins were grouped into three hierarchically structured GO terms: biological process, cellular component, and molecular function.](srep23565-f3){#f3}

![The protein-protein interaction networks of the differentially expressed proteins in STRING database.\
The signal pathways affected by the mushroom polysaccharides were clustered according to the network analysis. The solid lines represent direct interactions between proteins, and the dotted lines indicate indirect interactions between proteins.](srep23565-f4){#f4}

![Quantitative Real-time PCR analysis of the expression of the DJ-1 and 14-3-3 mRNA in the normal HepG2 cells and the cells treated with the PL, GL and AA polysaccharides.\
(**a**) Gene expression of DJ-1. (**b**) Gene expression of 14-3-3. Gene expression is normalized to β-actin expression. The data represent the mean ± SD. \**P* \< 0.05, \*\**P* \< 0.01.](srep23565-f5){#f5}

![Expression of the DJ-1 and 14-3-3 proteins in normal HepG2 cells and the cells treated with the PL, GL and AA polysaccharides.\
(**a**) The protein expression of DJ-1 by Western blotting analysis. (**b**) The protein expression of 14-3-3 by Western blotting analysis. The protein expression was normalized to β-actin expression.](srep23565-f6){#f6}

###### MS identification of differentially expressed protein spots in mushroom polysaccharide-treated HepG2 cells.

  Spots number   Protein name                                                                    gi number   matched peptiders   MALDI-TOF-MS sequence coverage   Protein scoreb   MW (Dalton)    PI
  -------------- ------------------------------------------------------------------------------ ----------- ------------------- -------------------------------- ---------------- ------------- ------
  3              ATP synthase subunit beta                                                       32189394           22                        47%                      125            56525      5.26
  8              heat shock protein beta-1                                                        4504517           10                        43%                       94            22826      5.98
  9              cellular retinoic acid-binding protein 2                                         4503029           12                        68%                      103            15854      5.42
  11             vimentin                                                                        62414289           38                        73%                      217            53676      5.06
  12             14-3-3                                                                           5803227           18                        59%                      109            28032      4.68
  13             neurone-specific enolase                                                         930063            25                        62%                      210            47467      4.94
  15             hCG1985580, isoform CRA_c                                                       119571372           9                        63%                      109            14498      5.05
  16             RNH1 protein                                                                    15029922           12                        38%                       86            50104      4.83
  18             Keratin 10                                                                      21961605           13                        28%                       95            59020      5.09
  19             keratin, type I cytoskeletal 9                                                  55956899           17                        41%                       94            62255      5.14
  20             vimentin variant 3                                                              167887751          24                        52%                      140            49680      5.19
  21             heat shock protein 27                                                            662841            14                        67%                      151            22427      7.83
  22             protein disulfide isomerase                                                      1710248           21                        65%                      239            46512      4.95
  23             Peroxiredoxin-4                                                                 49456297           11                        45%                      113            30742      5.86
  24             thiol-specific antioxidant proteins                                              1617118           12                        72%                      192            18486      5.19
  25             Tat binding protein 7                                                            263099            21                        56%                      165            51633      5.52
  26             mitochondrial ATP synthase                                                      89574029           28                        61%                      215            48083      4.95
  27             keratin, type I cytoskeletal 17                                                  4557701           42                        66%                      361            48361      4.97
  28             nucleoside diphosphate kinase A                                                 38045913           18                        80%                      160            19869      5.42
  29             prohibitin                                                                      46360168           24                        88%                      224            29859      5.57
  30             phosphatase 2A regulatory subunit                                                189428            21                        33%                      145            65232      5.1
  31             Glucose-regulated protein precursor                                              386758            26                        40%                      272            72185      5.03
  32             glutathione S-transferase P                                                     332837089          14                        63%                      127            23555      5.43
  35             Stress-70 protein, mitochondrial                                                24234688           40                        55%                      279            73920      5.89
  37             40S ribosomal protein SA                                                         9845502           19                        53%                      143            32947      4.79
  39             Heat shock 70 kDa protein 1A/1B                                                 167466173          31                        63%                      245            70294      5.48
  41             PDZ domain-containing protein                                                    5031715           16                        47%                      159            36141      5.9
  46             keratin 8                                                                       119617057          44                        62%                      236            57829      5.41
  47             peroxiredoxin-6                                                                  4758638           11                        44%                      104            25133       6
  48             heterogeneous nuclear ribonucleoprotein K                                       119583084          23                        55%                      171            49002      5.46
  53             chaperonin containing TCP1, subunit 6A isoform a variant                        62089036           31                        64%                      171            58239      6.25
  54             ubiquitin carboxyl-terminal hydrolase isozyme L3BAG family molecular             5174741           13                        53%                      121            26337      4.84
  57             chaperone regulator 2                                                            4757834           13                        51%                      110            23928      6.25
  60             prosome beta-subunit                                                             551547            14                        58%                      102            25950      5.7
  61             glycyltRNAsynthetase                                                             1311463           22                        35%                      122            83828      6.61
  68             leukocyte elastase inhibitor                                                    13489087           10                        35%                      100            42829      5.9
  70             Vinculin                                                                        24657579           26                        32%                      185           117234      5.83
  71             proteasome activator complex subunit 1                                           5453990           21                        65%                      199            28876      5.78
  73             annexin A1                                                                      119582950          13                        41%                       98            40475      6.57
  74             Heterogeneous nuclear ribonucleoprotein H                                       48145673           21                        52%                      118            49384      5.79
  75             Isocitrate dehydrogenase                                                         5031777           13                        28%                       97            40022      6.47
  76             Chaperonin containing TCP1, subunit 3                                           14124984           30                        46%                      233            60934      6.1
  77             keratin 1                                                                       11935049           18                        34%                       88            66198      8.16
  78             adenosine kinase isoform a                                                      32484973           26                        67%                      189            39078      6.23
  80             Chain A, Structure Of Human Tryptophanyl-TrnaSynthetase in Complex With Trna    112489952          13                        36%                      103            44408      7.26
  81             dihydropyrimidinase-related protein 2 isoform 2                                  4503377           29                        68%                      233            62711      5.95
  82             Chain A, Crystal Structure Of Human Enolase 1                                   203282367          16                        41%                       96            47350      6.99
  83             phosphoglycolate phosphatase                                                    108796653          12                        38%                       99            34441      5.85
  84             26S protease regulatory subunit 7 isoform 1                                      4506209           31                        64%                      231            49002      5.71
  85             heterogeneous nuclear ribonucleoprotein H2                                       9624998           26                        44%                      170            49517      5.89
  86             leukotriene A-4 hydrolase                                                        4505029           23                        40%                      158            69868      5.8
  87             60S acidic ribosomal protein P0                                                  4506667           20                        57%                      137            34423      5.71
  90             t-complex polypeptide 1                                                           36796            19                        39%                      129            60869      6.03
  91             aldehyde dehydrogenase, mitochondrial                                           25777732           17                        37%                       90            56859      6.33
  92             macrophage-capping protein isoform 2                                            371502127          14                        41%                       78            37119      6.72
  96             protein DJ-1                                                                    31543380           15                        70%                      129            20050      6.33
  97             Ezrin                                                                           46249758           43                        58%                      290            69313      5.94
  98             protein disulfide isomerase family A, member 3                                  119597640          27                        51%                      172            54454      6.78
  100            heat shock cognate 71 kDa protein isoform 1                                      5729877           28                        48%                      209            71082      5.37

###### Significantly enriched KEGG pathways of differentially expressed proteins.

       Pathway name                                      ID     Genes                                               Count   P-value
  ---- --------------------------------------------- ---------- -------------------------------------------------- ------- ----------
  1    Antigen processing and presentation            hsa04612  P08107,P30101,P11021,Q06323,P11142                    5     7.53e-05
  2    Proteasome                                     hsa03050  P35998,P28070,Q06323,P43686                           4     8.88e-05
  3    Epstein-Barr virus infection                   hsa05169  P08107,P04792,P35998,P08670,P27348,P11142,P43686      7     9.31e-05
  4    Protein processing in endoplasmic reticulum    hsa04141  P08107,P30101,O95816,Q15084,P11021,P11142             6     2.67e-04
  5    Glycolysis/Gluconeogenesis                     hsa00010  P09104,P06733,P05091                                  3     5.48e-03
  6    RNA degradation                                hsa03018  P38646,P09104,P06733                                  3     7.25e-03
  7    Amoebiasis                                     hsa05146  P30740,P04792,P18206                                  3     2.14e-02
  8    Spliceosome                                    hsa03040  P08107,P61978,P11142                                  3     3.44e-02
  9    Legionellosis                                  hsa05134  P08107,P11142                                         2     3.62e-02
  10   Pathogenic Escherichia coli infection          hsa05130  P15311,P27348                                         2     3.62e-02
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